Invex Therapeutics Ltd. (AU:IXC) has released an update.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Invex Therapeutics Ltd. has announced the expiration of 400,000 options on April 8, 2024, without exercise or conversion. The options were set to expire at a strike price of $0.91. This development may influence the company’s capital structure and potentially impact shareholder value.
For further insights into AU:IXC stock, check out TipRanks’ Stock Analysis page.